Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. (Q47267928)

12 January 2018

title

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. (English)

1 reference

12 January 2018

1 reference

9

Bertram Pitt

1 reference

12 January 2018

Michael A Weber

1

1 reference

12 January 2018

Kenneth Jamerson

2

1 reference

12 January 2018

George L Bakris

3

1 reference

12 January 2018

Matthew R Weir

4

1 reference

12 January 2018

Dion Zappe

5

1 reference

12 January 2018

Ying Zhang

6

1 reference

12 January 2018

Bjorn Dahlof

7

1 reference

12 January 2018

Eric J Velazquez

8

1 reference

12 January 2018

language of work or name

English

0 references

publication date

6 December 2012

1 reference

12 January 2018

published in

The Lancet

1 reference

12 January 2018

volume

381

1 reference

12 January 2018

page(s)

537-545

1 reference

12 January 2018

issue

9866

1 reference

12 January 2018

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

1 reference

7 January 2021

The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Impact of body mass index on cardiac mortality in patients with known or suspected coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Is hypertension more benign when associated with obesity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Enhanced risk of coronary heart disease mortality in lean hypertensive men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Obesity paradox in patients with hypertension and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Disparate cardiovascular effects of obesity and arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Obesity-induced hypertension. Renal function and systemic hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Neural mechanisms in human obesity-related hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Calcium-channel blockers and sodium intake: a controlled study in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Catecholamines and the Renin-Angiotensin-Aldosterone System During Treatment with Felodipine ER or Hydrochlorothiazide in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Benazepril plus amlodipine or hydrochlorothiazide for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Renal outcomes in hypertensive Black patients at high cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961343-9

7 January 2021

10.1016/S0140-6736(12)61343-9

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

23219284

1 reference

12 January 2018